ANTIHEMOPHILIC FACTOR (FACTOR VIII), RECOMBINANT-Fc - INJECTION
PHONETIC PRONUNCIATION: (AN-tye-HEE-moe-FIL-ik FAK-tor)
COMMON BRAND NAME(S): Eloctate
GENERIC NAME(S): antihemophilic factor (FVIII) recombinant, Fc fusion protein
Uses
USES: This medication is used to control and prevent bleeding that happens to people (usually males) with an inherited medical condition, hemophilia A (low levels of factor VIII). It is also given before surgery to prevent too much bleeding in people with this condition. Factor VIII is a protein (clotting factor) that is in normal blood, and helps form blood clots and stop bleeding after an injury. People with low factor VIII levels may bleed longer than normal after an injury/surgery and may have bleeding inside the body (especially in the joints and muscles). This medication contains man-made factor VIII (antihemophilic factor) to temporarily replace factor VIII in the body, connected to an antibody (immunoglobulin) that helps the man-made factor VIII work longer. When used to control and prevent bleeding, this medication may help relieve pain and long-term damage caused by hemophilia A. This medication should not be used to treat von Willebrand disease.
How to use ANTIHEMOPHILIC FACTOR (FACTOR VIII), RECOMBINANT-Fc - INJECTION
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start using this medication and each time you get a refill. If you have any questions, ask your doctor or pharmacist. This medication is given by injection into a vein as directed by your doctor, usually no faster than 10 milliliters per minute. The injection time may be different, depending on your dose and how you respond to it. After first receiving this medication in a clinic or hospital, some people may be able to give this medication to themselves at home. If your doctor directs you to use this medication at home, read and learn all preparation and usage instructions in the product package. Learn how to store and discard medical supplies safely. If you have any questions, ask your health care professional. If the medication and the solution used to mix it are refrigerated, take them out of the refrigerator ahead of time and let them come to room temperature before mixing. After mixing, gently swirl to completely dissolve the powder. Do not shake. Before using this medication, check it visually for particles or discoloration. If either is present, do not use the liquid. Use the mixed medication as soon as possible, but no later than 3 hours after mixing. Do not refrigerate the mixed medication. The dosage is based on your medical condition, weight, blood test results, and response to treatment. Children younger than 6 years may need higher doses. Follow your doctor's instructions carefully. Tell your doctor if your condition does not improve or if it worsens.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for ANTIHEMOPHILIC FACTOR (FACTOR VIII), RECOMBINANT-Fc - INJECTION
Antihe-mophilic Factor (Factor VIII), Recombinant-Fc is a medication used to treat and control bleeding in patients with Hemophilia A, a rare genetic bleeding disorder caused by a deficiency in clotting factor VIII.
Antihe-mophilic Factor (Factor VIII), Recombinant-Fc works by replacing the missing or deficient factor VIII in patients with Hemophilia A. It helps blood to clot and control bleeding episodes.
Antihe-mophilic Factor (Factor VIII), Recombinant-Fc is administered through injection, either into a vein (intravenous) or into a port catheter.
The dosage of Antihe-mophilic Factor (Factor VIII), Recombinant-Fc varies depending on the patient's weight, severity of the bleeding episode, and response to treatment. It is important to follow the instructions provided by the healthcare provider.
Common side effects of Antihe-mophilic Factor (Factor VIII), Recombinant-Fc may include headache, nausea, vomiting, fever, injection site reactions, and allergic reactions. It is important to seek immediate medical attention if severe allergic reactions occur.
It is advisable to consult a healthcare provider before using Antihe-mophilic Factor (Factor VIII), Recombinant-Fc during pregnancy or breastfeeding. They can provide guidance based on individual circumstances and the potential risks and benefits.
Antihe-mophilic Factor (Factor VIII), Recombinant-Fc may interact with certain medications, such as anticoagulants. It is important to inform the healthcare provider about all medications being taken to avoid any potential interactions.
Antihe-mophilic Factor (Factor VIII), Recombinant-Fc should be stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Do not freeze it. It should be protected from light.
If a dose of Antihe-mophilic Factor (Factor VIII), Recombinant-Fc is missed, it should be taken as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped and the regular dosing schedule should be followed.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet